On July 17, WuXi Biologics fell 3.26% in regular trading, trading at 37.54 HKD/share, with turnover of HKD 579 million.
Within the Life Sciences Tools & Services sector where WuXi Biologics belongs, the overall sector performance was notably weak. Among individual stocks, JOINN down 9.99%, INSILICO down 9.3%, WUXI XDC down 7.17%, XTALPI down 5.53%, WUXI APPTEC down 5.25%.
WuXi Biologics is a leading global biologics contract research, development, and manufacturing organization (CRDMO), providing end-to-end solutions and services from drug discovery to commercial manufacturing for global pharmaceutical companies, with business covering biologics and antibody-drug conjugates among other areas.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments